Satishkumar Singh

Years Active: 2023-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Anuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, Krysta Mila Coyle, Laura K Hilton, Evangelia Chavdoula, Parvathi Ranganathan, Neeraj Jain, Walter Hanel, Philip Tsichlis, Lapo Alinari, Blake R Peterson, Jianguo Tao, Natarajan Muthusamy, Robert Baiocchi, Narendranath Epperla, Ken H H Young, Ryan D Morin, Lalit Sehgal
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphoma. Leukemia (2023)
Fiona Brown-Burke, Inah Hwang, Shelby L Sloan, Claire Hinterschied, JoBeth Helmig-Mason, Mackenzie E Long, Wing Keung Chan, Alexander Prouty, Ji-Hyun Chung, Yang Zhang, Satishkumar Singh, Youssef Youssef, Neha Bhagwat, Zhengming Chen, Selina Chen-Kiang, Maurizio DiLiberto, Olivier Elemento, Lalit Sehgal, Lapo Alinari, Kris Vaddi, Peggy Scherle, Rosa Lapalombella, Jihye Paik, Robert A Baiocchi
PRMT5 Inhibition Drives Therapeutic Vulnerability to Combination Treatment with BCL-2 Inhibition in Mantle Cell Lymphoma. Blood advances (2023)

Satishkumar Singh.css-eqlu8i{font-size:small;padding-left:4px;}